Teriparatide biosimilar (Amega Biotech)

特立帕肽生物类似药(Amega Biotech)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTeriparatide biosimilar (Amega Biotech)
Drug Alias NameTeriparatidum (Amega Biotech)Recombinant human parathyroid hormone 1-34 follow-on biologicrhPTH (1-34) (Amega Biotech)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmega Biotech
China Registration ClassN/A

Develop Information

Active CompaniesAmega Biotech
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeH05AA02
Related LinksN/A